Genovate Biotechnology Co., Ltd. (TPEX:4130)
25.70
-0.40 (-1.53%)
Jun 18, 2026, 1:30 PM CST
23.36% (1Y)
| Market Cap | 2.92B +23.4% |
| Revenue (ttm) | 471.48M -6.2% |
| Net Income | -9.17M |
| EPS | -0.08 |
| Shares Out | 113.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | 0.10 (0.38%) |
| Ex-Dividend Date | Aug 20, 2025 |
| Volume | 80,036 |
| Open | 26.25 |
| Previous Close | 26.10 |
| Day's Range | 25.20 - 26.25 |
| 52-Week Range | 17.65 - 40.15 |
| Beta | 0.07 |
| Analysts | Buy |
| Price Target | 56.72 (+120.7%) |
| Earnings Date | Aug 11, 2026 |